Marieke E. Straver - Concepedia

Author

Marieke E. Straver

Also Known As

M E Straver, M Straver, M. E. Straver, M. Straver, M.E. Straver, Marieke E Straver, Marieke E. Straver, Marieke Evelien Straver, Marieke Straver

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Medisch Centrum Haaglanden European Organisation for Research and Treatment of Cancer Radboud University Nijmegen Leiden University Medical Center

About

Marieke E. Straver is an author at The Netherlands Cancer Institute specializing in oncology, breast cancer, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	2.9K
2	Health Sciences	9	9	667
3	Pathology	3	3	521
4	Engineering	1	1	255
5	Biostatistics	1	1	15

Marieke E. Straver

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial Mila Donker, Geertjan van Tienhoven, Marieke E. Straver, The Lancet Oncology Surgical OncologyBreast OncologyRadiation TherapyMedicineBreast Cancer	2014	1.8K
Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients Mila Donker, Marieke E. Straver, Jelle Wesseling, Annals of Surgery	2014	415
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial Sanne A. L. Bartels, Mila Donker, Coralie Poncet, Journal of Clinical Oncology	2022	322
Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype Claudette E. Loo, Marieke E. Straver, Sjoerd Rodenhuis, Journal of Clinical Oncology	2011	299
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer Marieke E. Straver, Annuska M. Glas, Juliane Hannemann, Breast Cancer Research and Treatment Tumor BiologyBreast OncologyOncologyEngineeringTumor Heterogeneity	2009	255
Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial Marieke E. Straver, Philip Meijnen, Geertjan van Tienhoven, Annals of Surgical Oncology	2010	244
Role of Axillary Clearance After a Tumor-Positive Sentinel Node in the Administration of Adjuvant Therapy in Early Breast Cancer Marieke E. Straver, Philip Meijnen, Geertjan van Tienhoven, Journal of Clinical Oncology Surgical OncologyBreast OncologyAdjuvant ChemotherapyAxillary Radiation TherapyOncology	2009	182
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response Jorma J. de Ronde, Juliane Hannemann, Hans Halfwerk, Breast Cancer Research and Treatment Surgical OncologyBreast OncologyMedicineMolecular Breast CancerPathology	2009	168
The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy Marieke E. Straver, Emiel J. Rutgers, Sjoerd Rodenhuis, Annals of Surgical Oncology	2010	134
Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer Marieke E. Straver, Claudette E. Loo, Tanja Alderliesten, British journal of surgery	2010	126

Page 1